Market Value232,252,000
Total Holdings68
File Date2016-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OFIX / Orthofix Medical Inc.
ELV / Elevance Health, Inc.
AKRX / Akorn, Inc.
BIO / Bio-Rad Laboratories, Inc.
TLGT / Teligent Inc
SPNC / Spectranetics Corp. (The)
US74975N1054 / RTI Surgical, Inc.
878193101 / TearLab Corp
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
AGRX / Agile Therapeutics, Inc.
LDRH / iShares Trust - iShares iBonds 1-5 Year High Yield and Income Ladder ETF
IRIX / IRIDEX Corporation
MYGN / Myriad Genetics, Inc.
LGND / Ligand Pharmaceuticals Incorporated
MDCO / Medicines Company
MRK / Merck & Co., Inc.
IONS / Ionis Pharmaceuticals, Inc.
/ Oxford Immunotec Global PLC
PETX / Aratana Therapeutics, Inc.
NSTG / NanoString Technologies, Inc.
STJ / St. Jude Medical, Inc.
CPHD / Cepheid
STRM / Streamline Health Solutions, Inc.
CYNA / Cynapsus Therapeutics Inc.
US29266S3040 / Endologix, Inc.
LMAT / LeMaitre Vascular, Inc.
HBIO / Harvard Bioscience, Inc.
HSTM / HealthStream, Inc.
SHPG / Shire Plc.
AMED / Amedisys, Inc.
DOC / Healthpeak Properties, Inc.
BIOS / BioPlus Acquisition Corp - Class A
US0906721065 / BioTelemetry, Inc.
ENTL / Entellus Medical, Inc.
CEMI / Chembio Diagnostics Inc.
KTWO / K2M Group Holdings, Inc.
NXTM / NxStage Medical, Inc.
AET / Aetna, Inc.
018490100 / Allergan plc
AMGN / Amgen Inc.
A / Agilent Technologies, Inc.
LLY / Eli Lilly and Company
/ Immunomedics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
BDX / Becton, Dickinson and Company
STE / STERIS plc
VRTX / Vertex Pharmaceuticals Incorporated
EVHC / Envision Healthcare Holdings, Inc.
CELG / Celgene Corp.
US00C4U1L353 / Mylan N.V.
/ Array BioPharma, Inc.
BMY / Bristol-Myers Squibb Company
LHCG / LHC Group Inc
QDEL / QuidelOrtho Corporation
TECH / Bio-Techne Corporation
JNJ / Johnson & Johnson
SNY / Sanofi - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
UTHR / United Therapeutics Corporation
BLUE / bluebird bio, Inc.
PFE / Pfizer Inc.
AVGR / Avinger, Inc.
NEO / NeoGenomics, Inc.
SAGE / Sage Therapeutics, Inc.
VCYT / Veracyte, Inc.
ALKS / Alkermes plc
ENZ / Enzo Biochem, Inc.
MODN / Model N, Inc.
HUM / Humana Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
ATRC / AtriCure, Inc.